Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 311 Nivolumab 159 Carboplatin 158 Cisplatin 140 Cyclophosphamide 135 Paclitaxel 129 Magnetic Resonance Spectroscopy 99 Specimen Handling 96 Radiotherapy 93 Gemcitabine 88 Dexamethasone 86 Biopsy 81 Ipilimumab 81 Docetaxel 78 Doxorubicin 77 Rituximab 71 Etoposide 69 durvalumab 62 Lenalidomide 61 Radiation 61 atezolizumab 60 Prednisone 59 Pemetrexed 58 Taxes 58 Bevacizumab 55 fludarabine 54 olaparib 53 Vincristine 52 Cytarabine 51 Fluorouracil 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × LY-2157299 × 1 year × Clear all

NCT01582269 2025-11-24

A Study in Recurrent Glioblastoma (GB)

Eli Lilly and Company

Phase 2 Completed

158 enrolled 20 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡